Drug Trial Radar · NCT07220759
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
330
Planned (sponsor's estimate)
Start
Nov 5, 2025
Primary completion
May 12, 2027
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Oct 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintide. Participant will either get cagrilintide or placebo. Which treatment participant get is decided by chance. Participants are two times more likely to get cagrilintide than placebo. Like all medicines, the study medicine may have side effects. For each participant, the study will last for about 1 year and 6 months.
Conditions
- Overweight
- Obesity
- Type 2 Diabetes
Interventions
CagrilintideDrug
Cagrilintide will be administered subcutaneously with a pen-injector as an adjunt to lifestyle intervention counselling.
Placebo (matched to Cagrilintide)Drug
Placebo matched to cagrilintide will be administered subcutaneously with a pen-injector as an adjunt to lifestyle intervention counselling.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative change in body weightTime frame: From baseline (week 0) to end of treatment (week 64)
Locations
67 sites in 11 countries. Site status is shown where the registry gives one.
Univ of Alabama_Birmingham
Birmingham, Alabama
Chambliss Clinical Trials, LLC
Montgomery, Alabama
Noble Clinical Research
Tucson, Arizona
Scripps Whittier Diabetes Inst
La Jolla, California
Headlands Research CTR Lincoln
Lincoln, California
Pacific Clinical Studies
Los Alamitos, California
Walgreens - Store 4442
Kissimmee, Florida
Optimal Research Sites
Orange City, Florida
Center for Diab,Obes & Metab
Pembroke Pines, Florida
Palm Beach Research Center
West Palm Beach, Florida
East West Med Res Inst
Honolulu, Hawaii
MediSphere Medical RC
Evansville, Indiana
Walgreens - Store 3915
Las Vegas, Nevada
Chear Center LLC
The Bronx, New York
Centricity Res New Bern Multispeciality
New Bern, North Carolina
Accellacare
Wilmington, North Carolina
Spartanburg Medical Research
Spartanburg, South Carolina
Holston Medical Group_Bristol
Bristol, Tennessee
Velocity Clinical Res-Dallas
Dallas, Texas
TPMG Clinical Research
Newport News, Virginia
National Clin Res Inc.
Richmond, Virginia
Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli
Buenos Aires, Argentina
Buenos Aires Mácula
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
CICEMO- Consultorio de Investigación Clínica EMO
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
OCT Research ULC (dba Okanagan Clinical Trials)
Kelowna, British Columbia, Canada
G.A. Research Associates Ltd.
Moncton, New Brunswick, Canada
Nova Scotia Hlth Halifax
Halifax, Nova Scotia, Canada
Centricity Research Brampton Endocrinology
Brampton, Ontario, Canada
Hamilton Medical Research Group
Hamilton, Ontario, Canada
Wharton Medical Clinic Clinical Trials (Hamilton)
Hamilton, Ontario, Canada
Milestone Research
London, Ontario, Canada
Centricity Res Pointe-Claire
Pointe-Claire, Quebec, Canada
Diex Recherche Victoriaville
Victoriaville, Quebec, Canada
Opca bolnica Karlovac
Karlovac, Croatia
Specijalna Bolnica za medicinsku rehabilitaciju Krapinske Toplice_Endocrinology
Krapinske Toplice, Croatia
Poliklinika SLAVONIJA OSIJEK
Osijek, Croatia
Poliklinika Solmed
Zagreb, Croatia
Lékařský dům Géčko
České Budějovice, Czechia
Milan Kvapil s.r.o.
Prague, Czechia
EUC Klinika Praha a.s.
Prague, Czechia
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.